Skip to main content

CRISPR gene editing to take on inherited blindness in U.S. study

A new study in the United States will use CRISPR gene-editing technology to treat Leber congenital amaurosis (LCA), a retinal condition that is a major cause of inherited blindness. The study, which will take place later in 2019, is currently open for would-be patients to enroll.

LCA affects roughly one in 80,000 people, making it the most common form of inherited sight loss among children. The condition causes the light-sensing photoreceptor cells at the back of the eye to stop functioning correctly. Symptoms can involve poor peripheral vision, night blindness, and faulty pupil reactions. Over time, these conditions can worsen; leaving patients able to only detect the faint outlines of shapes or even totally blind.

The test will evaluate a gene therapy named AGN-151587 as a treatment for LCA. The study will assess safety, tolerability, and efficacy of this treatment in 18 patients. Patients in the study will receive a single dose of AGN-151587 administered using a subretinal injection in the eye.

“We are very proud of our continued commitment to developing innovative treatments for unmet needs in eye care,” David Nicholson, Chief R&D Officer at Allergan, said in a statement. “Beginning patient enrollment in the AGN-151587 clinical trial with our partners at Editas is an important step toward our goal of developing a game-changing, transformative, CRISPR-based medicine for people with LCA10.”

This is a significant advance in the usage of CRISPR gene-editing technology. Since bursting onto the scene a decade ago, CRISPR has opened up a slew of new possibilities — from the creation of malaria-resistant mosquitoes to, as this study could help confirm, life-changing medical advances. CRISPR got a bad rap last year when it was used as part of a controversial Chinese experiment in which gene-editing was used on embryos or infants. Unlike that widely condemned experiment, this work involves fully grown consenting adults.

“Now that enrollment is underway, we are one step closer to delivering a transformative medicine to LCA10 patients,” Charles Albright, Chief Scientific Officer of Editas Medicine, one of the other companies involved with the study, said in a press statement. “The team at Editas looks forward to continuing to collaborate with our partners at Allergan, patient advocacy organizations, and the inherited retinal diseases community as we develop this and other durable experimental medicines for patients with devastating ocular diseases.”

Editors' Recommendations

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Rocket Lab selects U.S. site to launch, land next-gen rocket
Rocket Lab's Neutron rocket.

Rocket Lab highlighted its growing ambitions as a spaceflight company this week when it announced NASA’s Wallops Flight Facility in Virginia as the launch site for upcoming missions that will use its next-generation Neutron rocket.

Rocket Lab said it will also build Neutron at Wallops and use the location to prepare and conduct Neutron missions.

Read more
These Black pioneers were pillars of the U.S space program
Bolden on the flight deck of Discovery during STS-60.

When you think about America’s space program, your mind probably jumps to Neil Armstrong and Buzz Aldrin walking on the moon, the space race between America and the USSR, or perhaps some of the agency's famous crafts like the space shuttle or the Hubble Space Telescope. But behind all those iconic moments, memories, and machines is NASA’s unique place in America’s racial struggle.

Over the course of its history, NASA has both participated in racial discrimination and contributed to the fight against it. Like many other places in America, the agency that later became NASA, called the National Advisory Committee for Aeronautics (NACA), participated in racial segregation. That ended when it became NASA in 1958, but the underlying racial issues of its past echoed for years to come.

Read more
Circular confirms its $259 smart ring is coming to the U.S.
best wearables of ces 2022 circular ring

The Circular smart ring is finally going to be available for pre-order on Sunday, February 27, via the Circular website and will cost $259. The wearable tech will be available for presale in European countries (France, Germany, the U.K., and Italy,) the United States, Australia, Hong Kong, and Singapore. Pre-orders will go live at 1:30 p.m. ET on Sunday, February 27. Those who pre-order the smart ring should expect delivery between April and June 2022, according to a Circular press release.

Circular doesn't clarify what ring sizes will be available when presales go live, however, the company has said that seven sizes for both men and women will be available. Digital Trends has reached out for clarification on the available sizes, and will update this article when we hear back. The Circular smart ring also comes in four different colors that can be switched out with replaceable outer shells: Black, rose gold, silver, and gold.

Read more